Elabd W, Elbakry M, Hassany M, Baki A, Seoudi D, El Azeem E
Clin Exp Hepatol. 2023; 9(3):221-227.
PMID: 37790691
PMC: 10544064.
DOI: 10.5114/ceh.2023.130547.
Abu-Shahba N, Hegazy E, Khan F, ElHefnawi M
Cancer Inform. 2023; 22:11769351231171743.
PMID: 37200943
PMC: 10185868.
DOI: 10.1177/11769351231171743.
Mokhtari F, Mohebbi S, Sharifian A, Ramandi M, Razzaghi M
Gastroenterol Hepatol Bed Bench. 2022; 14(Suppl1):S10-S23.
PMID: 35154598
PMC: 8817748.
Liu X, Zhang H, Zhou P, Yu Y, Zhang H, Chen L
Oncol Rep. 2021; 45(5).
PMID: 33786634
PMC: 8020205.
DOI: 10.3892/or.2021.8030.
Tang J, Xiao X, Jiang Y, Tian Y, Peng Z, Yang M
J Hepatocell Carcinoma. 2020; 7:257-269.
PMID: 33154957
PMC: 7605949.
DOI: 10.2147/JHC.S271091.
Inhibiting the proliferation and metastasis of hilar cholangiocarcinoma cells by blocking the expression of vascular endothelial growth factor with small interfering RNA.
Xiao K, Ouyang Z, Tang H
Oncol Lett. 2018; 16(2):1841-1848.
PMID: 30008874
PMC: 6036491.
DOI: 10.3892/ol.2018.8840.
Down-regulation of miR-146a-5p and its potential targets in hepatocellular carcinoma validated by a TCGA- and GEO-based study.
Zhang X, Ye Z, Liang H, Ren F, Li P, Dang Y
FEBS Open Bio. 2017; 7(4):504-521.
PMID: 28396836
PMC: 5377416.
DOI: 10.1002/2211-5463.12198.
miR-21a-5p Contributes to Porcine Hemagglutinating Encephalomyelitis Virus Proliferation via Targeting CASK-Interactive Protein1 and .
Lv X, Zhao K, Lan Y, Li Z, Ding N, Su J
Front Microbiol. 2017; 8:304.
PMID: 28298907
PMC: 5331037.
DOI: 10.3389/fmicb.2017.00304.
HBx promotes cell proliferation by disturbing the cross-talk between miR-181a and PTEN.
Tian Y, Xiao X, Gong X, Peng F, Xu Y, Jiang Y
Sci Rep. 2017; 7:40089.
PMID: 28053323
PMC: 5215388.
DOI: 10.1038/srep40089.
MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6.
Zu Y, Yang Y, Zhu J, Bo X, Hou S, Zhang B
Am J Cancer Res. 2016; 6(11):2502-2513.
PMID: 27904767
PMC: 5126269.
MiR-221 promotes IgE-mediated activation of mast cells degranulation by PI3K/Akt/PLCγ/Ca(2+) pathway.
Xu H, Gu L, Yang Q, Zhao D, Liu F
J Bioenerg Biomembr. 2016; 48(3):293-9.
PMID: 27113449
DOI: 10.1007/s10863-016-9659-7.
A micro-RNA expression signature for human NAFLD progression.
Guo Y, Xiong Y, Sheng Q, Zhao S, Wattacheril J, Flynn C
J Gastroenterol. 2016; 51(10):1022-30.
PMID: 26874844
PMC: 4983265.
DOI: 10.1007/s00535-016-1178-0.
Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.
Fahrner R, Dondorf F, Ardelt M, Dittmar Y, Settmacher U, Rauchfuss F
World J Gastroenterol. 2015; 21(42):12071-82.
PMID: 26576092
PMC: 4641125.
DOI: 10.3748/wjg.v21.i42.12071.
microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F, Lu Z, Chen B, Dong P, Zheng J
Diagn Pathol. 2015; 10:129.
PMID: 26215970
PMC: 4517483.
DOI: 10.1186/s13000-015-0369-y.
Emerging role of microRNA in hepatocellular carcinoma (Review).
Gong J, He X, Tian D
Oncol Lett. 2015; 9(3):1027-1033.
PMID: 25663852
PMC: 4315036.
DOI: 10.3892/ol.2014.2816.
microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
Zhang Z, Zhang Y, Sun X, Ma X, Chen Z
Mol Cancer. 2015; 14:5.
PMID: 25608619
PMC: 4326400.
DOI: 10.1186/1476-4598-14-5.
Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma.
He X, Li J, Guo W, Liu W, Yu J, Song W
Oncotarget. 2014; 6(4):2302-14.
PMID: 25544773
PMC: 4385853.
DOI: 10.18632/oncotarget.2955.
Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN).
Damania P, Sen B, Dar S, Kumar S, Kumari A, Gupta E
PLoS One. 2014; 9(3):e91745.
PMID: 24633222
PMC: 3954734.
DOI: 10.1371/journal.pone.0091745.
An integrative meta-analysis of microRNAs in hepatocellular carcinoma.
ElHefnawi M, Soliman B, Abu-Shahba N, Amer M
Genomics Proteomics Bioinformatics. 2013; 11(6):354-67.
PMID: 24287119
PMC: 4357785.
DOI: 10.1016/j.gpb.2013.05.007.
Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma.
Zhang M, Zhou X, Wang B, Yung B, Lee L, Ghoshal K
J Control Release. 2013; 168(3):251-61.
PMID: 23567045
PMC: 3672318.
DOI: 10.1016/j.jconrel.2013.03.020.